Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2865-2868

  Kirkpatrick, W R ^a   McAtee, R K ^a   Fothergill, A W ^a   Rinaldi, M G ^a   Patterson, T F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CEFTAZIDIME; ITRACONAZOLE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GUINEA PIG; IMMUNE DEFICIENCY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

AMPHOTERICIN B; ANIMAL; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS, SYNTHETIC; GUINEA PIGS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; ORGAN CULTURE; PYRIMIDINES; SUPPORT, NON-U.S. GOV'T; TRIAZOLES;

EID: 0033797988     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2865-2868.2000     Document Type: Article

References (21)

1. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole and amphotericin
2. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
3. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
4. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus
5. Invasive aspergiliosis
6. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
7. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
8. New antifungal agents
9. Experimental murine aspergillosis: Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191
10. Aspergillus fumigatus and aspergillosis
11. Optimizing voriconazole susceptibility testing of Candida: Effects of incubation time, endpoint role, species of Candida, and level of fluconazole susceptibility
12. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs
13. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus
14. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models
15. The efficacy of itraconazole solution in experimental invasive aspergillosis
16. The efficacy of SCH-39304 in experimental invasive aspergillosis
17. Treatment of experimental invasive aspergiilosis with novel amphotericin B/cholesterol-sulfate complexes
18. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model
19. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen
20. In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates